An observational study in Brain Tumor, sponsored by University of Minnesota. Terminated at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2022-06-28.
Sponsored by University of Minnesota · Observational
This project attempts to correlate wireless activity data with quality of life and sleep surveys in order to find a new method of monitoring patients during their treatment.
This project proposes the investigation, validation, and use of a wireless activity tracker to better understand and improve the quality of life of patients suffering from brain tumors. The Fitbit flex wireless syncing activity tracker will be distributed to 75 patients, and the electronic infrastructure to automatically track patients will be created and adapted for the cohort. Surveys will routinely assess the ease-of-use and any problems arising. This heterogenous population of patients suffering from brain tumors will be tracked and compared through routine evaluation of their quality of life through well-established surveys, including the SF-36 and FACT-Br. The association between data recorded from the activity tracker and the QOL surveys will be quantified to validate the activity tracking data as a surrogate measure of part, if not all, of QOL as well as sleep.
1,993 studies on the registry are indexed under Brain Neoplasms; 516 are open to participants now.
This study's enrollment of 29 is below the median of 100 across 389 observational studies indexed under Brain Neoplasms.
Browse Brain Neoplasms studies →University of Minnesota is the lead sponsor of 1,210 studies on the registry; 194 are open to participants now.
Of its 133 completed or terminated interventional studies of FDA-regulated products, 92 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Consentable patients suffering from a single or multiple primary or metastatic brain tumors
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with brain tumor(s) will be give a wireless activity tracker (fitbit flex) to use during treatment. They will complete quality of life surveys and a sleep survey.
Device: Wireless Activity tracker: Fitbit
Patients will wear a Fitbit flex
Activity measured in steps
Time frame: 1 year delineated by minute
Sleep
wireless activity will attempt to monitor sleep cycles when the device is worn
Time frame: per night over 1 year
Quality of Life - SF-36
SF-36
Time frame: months 0, 3, 6, 9, and 12
Quality of Life - Fact- Br
Fact-Br
Time frame: months 0, 3, 6, 9, and 12
Plan to share: No — Individual data will not be shared. De-identified group data will be made available
No publications or documents are linked to this record.
This study is terminated, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.